Organogenesis, Inc. v. Andrews

MEMORANDUM OF DECISION

ZOBEL, District Judge.

Appellant Organogenesis, Inc. appeals from a bankruptcy court decision. Appellant is a biomedical company whose main product is Apligraf, a living skin supplement used to treat venous leg and diabetic foot ulcers. Sixty-five percent of the company’s workforce manufacture Apligraf, which accounts for 95% of its revenue. Appellant owns the manufacturing rights to Apligraf, but contracted the exclusive worldwide marketing and distribution rights to Novartis Pharma AG (“Novartis”). The contract obligated appellant to sell Apligraf to Novartis at a price…